Maria Palasis has been serving as a member of our board of directors since 2022. Maria is currently President, Chief Executive Officer, and Board Director of Lyra Therapeutics, a combination product Biotechnology company she took public in 2020. Prior to Lyra Therapeutics, Maria was President, CEO, and Board Director of both Arsenal Medical and its spin-out, 480 Biomedical. Maria also served in senior leadership roles at Boston Scientific Corporation, Inc. focused on the development of drug-device combination products. She was elected into the National Academy of Engineering in 2021 for outstanding contributions to the design of medical devices and drug delivery systems. Maria serves on the Board of Directors of PanTher Therapeutics and is on the Advisory Board of MedExecWomen. She holds a B.S. and Ph.D. in Chemical Engineering from the University of Cincinnati and completed her postdoctoral fellowship in Molecular Biology at the University of Cincinnati School of Medicine.